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ABSTRACT
SELECTIVE FORCES THAT SHAPE THE VLS ANTIGENIC VARIATION SYSTEM
IN BORRELIA BURGDORFERI
Wei Zhou
Dustin Brisson
Evolutionary success of microbial pathogens requires survival within hosts, despite the
rapidly changing and lethal immune response. Pathogens such as the Lyme disease
bacteria Borrelia burgdorferi have evolved antigenic variation systems that are necessary
for survival within the adverse immune environment. Although antigenic variation
systems are essential to both microbial pathogenesis and microbial evolution, it is largely
unclear what selective forces have influenced the evolution of antigenic variation systems.
In this thesis, we investigate evolution of the vls antigenic variation system in B.
burgdorferi by asking two major questions: First, what traits relevant to the vls antigenic
variation system have natural selection acted on? Second, how did the selective forces
shape the genetic sequences of the vls antigenic variation systems? We characterize
sources of natural selection using mathematical modeling, computational simulation and
mutagenesis experiments. Our findings show that natural selection has promoted
diversity among VlsE variants on both sequence and structure by organizing the variable
sites in the vls unexpressed cassettes. We also show that the level of diversity among the
VlsE variants may strongly influence the within-host dynamics of Bb, an important
fitness component of B. burgdorferi. Finally, our results indicate that diversity among
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VlsE variants might be constrained by purifying or stabilizing selections on translational
efficiency and structural stability of the VlsE variants.
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Chapter 1. Introduction
1.1. Background: Rapidly changing host immune environment
All reproducing organisms are faced with changing environments and have to cope with
the potential decrease in fitness caused by environmental changes. Although
environmental changes with minimal fitness impact may be simply tolerated,
evolutionary success often requires changes in morphology, physiology or behavioral
traits to maintain high fitness in the face of large environmental changes [1-3]. The
ability to respond to environmental changes is especially important for the evolutionary
success of plants and microbes because they have limited mobility and are less capable of
physically escaping from changed environments [4]. A fundamental question in microbial
evolution is how microbes manage to survive within rapidly changing environments.
The host immune system is a particularly adverse and rapidly fluctuating environment for
microbial parasites. The host’s immune response to an invading parasite consists of a
variety of components that are spatially and temporally variable. One typical mechanism
of the response is the antibody-mediated adaptive immune response. Clones of antibodyproducing B cells are selected from a pool of up to 109 clones to maximize affinity of
antibodies to the invading parasite. Selected clones of B cells then secrete antibodies that
bind to parasitic antigens with a high affinity. This process happens repeatedly to keep
the antibody population highly reactive to newly expressed parasitic antigens. Moreover,
changes in B cell populations can happen very rapidly: in young rats, newly proliferated
B cells can replace the peripheral B cell pool within days [5]. The high-affinity antibodies
1

bind to parasitic antigens, recruiting immune effector cells and immune effector
molecules to efficiently remove the antibody-bound parasite cells. Therefore, antibody
response creates a rapidly changing and adverse environment for microbial parasites.

1.2. Background: Antigenic variation systems in microbial parasites
The parasites need to persist within hosts despite the lethal antibody response so as to
elevate within-host density of the parasites and to increase the probability of transmission
to naïve hosts [6, 7], both of which are vital fitness components. The ability of microbial
parasites to introduce antigenic diversity is essential to surviving the antibody response.
The reasons are twofold: First, due to specificity of the antibody response, diversity
among the parasitic antigens is needed to facilitate the evasion of antibody recognition
and killing. It has been suggested that the probability that a subset of the parasite
population can evade the antibody response is a function of the diversity of antigens
within the host [8]. Second, the parasite population continues to lose standing variation
due to a dynamic selection imposed by the antibody population. That is, only a subset of
parasitic antigens can evade each antibody, and if new variation is not generated in time,
that subset will also become extinct when the antibody population evolves to target the
subset.
As an adaptation to the immune environment, a lot of microbial parasites have evolved
mechanisms to promote diversity at a rate higher than expected given the genome-wide
mutation rate. These mechanisms include hypermutation at contingency loci, phase
variation and antigenic variation [9, 10]. Contingency loci are regions of highly mutable
2

DNA which often encode proteins located at the interface between the microbe and the
environment [7]. These loci usually mutate in a stochastic manner (ie. without sensing the
environment) to rapidly and continuously generate genetic variations, and thus arguably
facilitate adaptation to changing environments by increasing evolvability [11-13]. Phase
variation describes a reversible and often random switch between gene expression
profiles which can occur at a rate as fast as 1 switch per 10 replications [10]. Microbial
parasites switch between different phases during different stages of pathogenesis due to
significant environmental changes [14-16]. Although similar to normal gene regulation,
phase variation is distinctive in that it involves some forms of heritability, either genetic
or epigenetic, of the altered phenotype [10].
Antigenic variation refers to the alternation of a particular surface antigen through DNA
rearrangement [10, 17]. In terms of molecular mechanisms, such rearrangement is
commonly realized through homologous recombination between an expression locus and
a library of unexpressed, silent paralogs. As an example, Borrelia burgdorferi (Bb), the
causative agent of Lyme disease, takes advantage of a cassette-based mechanism to evade
the host immune response against its surface antigen VlsE (Figure 1-1) [18, 19]. VlsE is a
35kDa surface lipoprotein that is antigenically dominant when the bacteria infect
vertebrate hosts. Each Bb genome has an array of 10-20 unexpressed cassettes that are
paralogous to vlsE and are located within the linear plasmid lp28-1. DNA sequences of
the vls cassettes are very similar to the cassette region of vlsE, but also have mutations
that are concentrated in six variable regions. Random segments of the silent cassettes are
continuously introduced into vlsE through homologous and nonreciprocal recombination,
3

altering the sequence and the structure of the VlsE antigen [18-20]. It has been shown
that without the vls antigenic variation system, the infection duration and the ability of Bb
to disseminate to different tissues of laboratory mice are dramatically reduced [21-24].
Microbial pathogens benefit from antigenic variation in several ways. First, antibodies
that specifically target the original form of an antigen may have a decreased affinities to
the protein variants [8, 9, 17, 25]. Second, antigenic variation increases polymorphism in
the transmittable pool of pathogens, which increases the success rate in reinfection or
transmission [8, 25]. Third, when a host primed by the original form of an antigen is met
with a variant of the same antigen, it tends to activate a memory response against the
original antigen instead of a primary response against the variant [25]. In this case, the
memory response will likely be inefficient because it does not specifically target the
antigenic variant. This phenomenon, known as the Hoskins effect, infers that
polymorphism in a transmittable pool can not only permit reinfection, but might also
render the host more susceptible after a primary infection [25]. Finally, variability of
antigens may help counter the variability in immune systems among hosts with different
genetic backgrounds [25].
In addition to its importance in microbial infection, antigenic variation systems are a
suitable model to study microbial responses to rapidly fluctuating environments. For
recombination-based antigenic variation systems such as the vls antigenic variation
system, the genetic information for all possible antigenic variants is encoded in the
sequences of the paralogs [9, 10, 26]. Therefore, the antigenic variants that a parasite can
express can be explored by analyzing the sequences of the antigenic paralogs. For the vls
4

antigenic variation system in Bb, antigenic variants of vlsE continuously sample DNA
segments from the unexpressed cassettes. Therefore, selective pressure on the antigenic
variants imposed by the immune system is in turn reflected in the sequences of the
unexpressed cassettes. Earlier work has shown evidence of strong diversifying selection
in the unexpressed cassettes of the vls antigenic variation system: the dN/dS ratio among
the unexpressed cassettes is exceptionally high, which indicates that the unexpressed
cassettes are under strong selection for the probability of amino acid alterations within
the expression site [27]. This is likely because diversity among the unexpressed cassettes
need to be elevated to ensure that the newly generated VlsE variants are divergent enough
from the parental VlsE targeted by the antibodies, so as to evade the recognition of the
extant antibodies.
Despite the strong diversifying selection, not all sites are variable even within the
variable regions of vlsE. The existence of invariant sites suggests that either variation at
the invariant sites has little effect on immune recognition, or purifying selection has
limited the variability at these sites. Purifying selections may act on protein-coding genes,
including antigens of parasites, because changes that disrupt the structure or function of
the protein are detrimental. Although the full function of VlsE is yet unclear, it has been
suggested that VlsE can protect cell surface proteins from immune responses because of
its immunodominance [28], high level of expression within vertebrate hosts [29, 30] and
co-localization with other cell surface proteins [21]. Excessive alteration in the sequence
of the antigen can potentially undermine its efficiency in expression, correct folding,
structural stability and resistance to proteases [31]. Therefore, antigenic variation systems,
5

including vls, should be selected to promote antigenic diversity, but only within
constraints of the structural and functional integrity of the antigen [10].

Figure 1-1. vls antigenic variation system in Bb. (A) the vlsE expression site and an array
of unexpressed vls cassettes are located on the linear plasmid lp28-1 in Bb. (B) the
cassette region of vlsE and the vls unexpressed cassettes are composed of variable regions
(VR) with a high concentration of mutations and invariable regions (IR) that are highly
conserved among the cassettes.

1.3. Scientific questions and dissertation structure
6

Despite the importance of antigenic variation systems in microbial pathogenesis and
microbial evolution, it is largely unknown how natural selection, including diversifying
selection and purifying selection, organize the genetic sequences of antigenic variation
systems. For example, in the vls antigenic variation system, it is unclear what sources of
selection have acted on the VlsE variants and how these selective forces have influenced
the sequences of the vls unexpressed cassettes. This dissertation investigates potential
sources of natural selection that have organized variable sites within the vls unexpressed
cassettes.
Chapter 2 presents a study of potential sources of natural selection affecting the
nucleotide identities at, and positions of, the variable sites within the variable regions of
the unexpressed vls cassettes. The study uses computational modeling and simulation to
investigate how perturbations in the variable and invariant nucleotides within the variable
regions of the unexpressed cassettes alter diversity and translational efficacy among the
resulting VlsE variants. The results suggest that the nucleotide identities and positions of
the variable sites are selected for higher sequence diversity among the VlsE variants
within strong constraints on protein translational ability.
Chapter 3 examines the influence of diversity among variants of VlsE on Bb dynamics
within hosts. Dynamics models are used to describe temporal changes in VlsE variant
types, antibody response, immune effector cells and Bb abundance within-host.
Numerical simulation based on the models predicts that diversity among antigenic
variants significantly influence Bb dynamics when Bb is strongly suppressed by the
immune system.
7

Chapter 4 investigates sources of natural selection acting on structure-level properties of
the VlsE antigen. We test the hypothesis that variable amino acid residues in the variable
regions of VlsE are more likely targeted by antibodies than the invariable residues in the
variable regions of VlsE. A correlation between variability and antigenic importance of
amino acid residues within the variable regions of VlsE is supported by computational
analysis, but not consistently supported by experimental analysis. We discuss possible
mechanisms that may lead to the discrepancy.

8

Chapter 2. Selection for sequence diversity and
translational efficacy among VlsE variants
This chapter was adapted from:
Zhou, W. and D. Brisson. 2014. Potentially conflicting selective forces that shape the vls
antigenic variation system in Borrelia burgdorferi. Infect Genet Evol. 27:559-65.

2.1. Introduction
The persistence within vertebrate hosts in the face of the potentially lethal environmental
conditions imposed by the immune system is a primary constituent of the evolutionary
fitness of many microbial pathogens [6, 8, 32, 33]. These strong selective pressure
imposed by the immune response has resulted in antigenic variation mechanisms evolved
to cope with this rapidly changing environment [6-8, 25, 33].
Antigenic variation systems alter surface antigens of pathogens, giving rise to
subpopulations of pathogens with distinct antigenic variants that are not recognized by
antibodies targeting previously detected antigens [10]. Antigenic variation systems that
more efficiently alter surface antigens of the pathogen are likely to be selectively
advantageous as they promote greater residence time within hosts and transmission to
naïve hosts, both of which are primary components of pathogen fitness.
One common molecular mechanism of antigenic variation involves recombining gene
fragments from unexpressed, paralogous cassettes into an expression site, thereby altering
the sequence of the expressed antigen. In these types of recombination-based antigenic
9

variation systems, which are common in several bacterial genera [18, 34, 35], the ability
to alter the sequence of the expressed antigen is correlated with the amount of diversity
among the unexpressed cassettes. Thus, natural selection should favor ever greater
diversity among unexpressed cassettes to promote ever greater divergence among
expressed antigens [27, 36]. However, the extent of the divergence among cassettes can
be constrained by other features of the system [37] . Here, we use the well-characterized
vls antigenic variation system in the Lyme disease bacterium, Borrelia burgdorferi (Bb),
as a model system to investigate the interactions between selection favoring greater
antigenic divergence and other potential constraints on antigenic variation systems.
Bb requires continuous alteration of the highly-expressed VlsE antigen for long-term
survival within hosts [18, 22-24, 38, 39]. A fragment of an unexpressed vls cassette can
be introduced into the vlsE expression site through nonreciprocal recombination, thus
changing, adding, or removing nucleotides in sequence of the expression site resulting in
the expression of a divergent VlsE antigen. However, altering the sequence in the
expression site could potentially reduce the ability to translate a functional protein– by
introducing stop codons or frameshift mutations – or reduce translational efficiency and
accuracy– by introducing non-preferred codons [20, 40]. Little is currently known about
how selection on both antigenic divergence and translational ability or efficiency
constrains the nucleotide identities at the variable sites, positions of the variable sites and
positions of the insertion/deletion mutations.
Here we evaluated the effects of the identity of nucleotides at variable sites, positions of
the variable sites, and position of insertion/deletion mutations in the unexpressed
10

cassettes on the divergence among VlsE variants as well as their translational ability and
translational efficiency. We ask if the organization of variable sites and insertion/deletion
mutations in the unexpressed cassettes of multiple natural strains promotes sequence
divergence, translational ability, and translational efficiency in the VlsE variants. We
used in silico simulation models to test if perturbing the observed variable sites leads to a
decrease in sequence divergence, translational ability and translational efficiency.

2.2. Materials and Methods
2.2.1. Sequence analysis of vlsE and the unexpressed cassettes
The sequences of the unexpressed cassettes from six strains of Bb and one B. afzelii strain
were used to investigate how diversifying selection and translational selection constrain
identities and locations of variable sites among the unexpressed cassettes (Table 2-1).
Each of the unexpressed cassettes within each strain was aligned using ClustalW [41]
with default parameters. The unexpressed vls cassettes from all strains have six or seven
variable regions in which variable sites are concentrated as described by Zhang et al [18].
Unexpressed cassettes that did not include all variable regions were not analyzed.

11

Strains
B31
JD1
WI9123
29805
Bol26
Zs7
B. afzelii

Number of
polymorphic sites
191

Number of
variable regions
6

166
115
140
234
90
223

6
6
6
6
6
7

Reference
Zhang et al. [20] Schutzer,
Fraser-Liggett [42]
Schutzer, Fraser-Liggett [42]
Schutzer, Fraser-Liggett [42]
Schutzer, Fraser-Liggett [42]
Schutzer, Fraser-Liggett [42]
Schutzer, Fraser-Liggett [42]
Wang, Botkin [43]

Table 2-1. Unexpressed cassettes in six strains of Bb and in B. afzelii

2.2.2. In silico perturbation of unexpressed cassettes
For each set of natural cassettes, three perturbation models were generated using the three
algorithms (δNuc, δPos, and δInDel) described below and in Figure 2-1. The perturbation
models have altered either a) nucleotide identity at each variable site (δNuc), b) the
locations of the variable sites within the variable regions (δPos), or c) the locations of
insertion/deletion mutations within the variable regions (δInDel). All perturbation models
were run independently on each strain to generate 50 iterations of perturbed cassettes.
The maximum-likelihood nucleotide substitution rates at the vls unexpressed cassettes in
each strain was estimated under the General Time Reversible (GTR) nucleotide
substitution model [44], which allows for different nucleotide frequencies and nucleotide
substitution rates, using PhyML [45]. The maximum-likelihood substitution model was
used to estimate the stationary frequencies of nucleotides in the unexpressed cassettes,
12

which was subsequently compared to the observed frequencies of nucleotides in the
unexpressed cassettes. If the two frequency distributions were not significantly different,
we concluded that nucleotide substitution has reached equilibrium among the
unexpressed cassettes. To show that the model predictions are robust to the choice of
nucleotide substitution model, perturbed cassettes that have altered nucleotide identities
at the variable sites (δNuc) or locations of the variable sites (δPos) were generated by
sampling nucleotides from both the maximum-likelihood stationary distribution and a
uniform distribution assuming equal rate of substitution between any pair of nucleotides.
2.2.2.1. δNuc algorithm
The δNuc algorithm converts the nucleotides observed at every variable site in the
cassettes of each natural strain to an alternative nucleotide (Figure 2-1A). That is, all
nucleotides of identity X are converted to identity Y (for example, all adenines at a given
variable site are converted to cytosines). The identity of the nucleotide to replace the
original nucleotide is sampled either at random or from the maximum-likelihood
stationary nucleotide frequency at the locus for each polymorphic site in each iteration of
the model. Nucleotide conversion is bijective – all nucleotides at a variable site of
nucleotide identity X will be converted to identity Y, and nucleotides of identity Y will
only be used to replace identity X at that variable site. The δNuc algorithm only replaces
nucleotides that differ from that observed in the vlsE sequence such that the total number
of nucleotides that differ from the parental vlsE is not altered.
2.2.2.2. δPos algorithm
The δPos algorithm relocates the position of all variable sites of a given strain except
13

those sites that contain insertion/deletion mutations, to a random position within the
variable regions of the unexpressed cassettes (Figure 2-1B). The nucleotide identities at
the relocated variable sites are altered following the δNuc algorithm (2.2.2.1).
2.2.2.3. δInDel algorithm
The δInDel algorithm relocates the position of all variable sites, including those that
contain insertion/deletion mutations, to random positions within the variable regions of
the unexpressed cassettes (Figure 2-1C). The nucleotide identities at the relocated sites
are sampled at random as in the δNuc algorithm (2.2.2.1), with the addition of gap as a
fifth possible type of ‘nucleotide’ that can be replaced and can be used for replacement.

14

Figure 2-1. Examples of algorithms perturbing the organizations of polymorphic sites. (A)
δNuc converts the polymorphic nucleotides to alternative nucleotides. (B) δPos relocates
polymorphic sites within the variable regions. The relocated polymorphic sites are then
perturbed as in δNuc. (C) δInDel relocates the polymorphic sites including those with
15

insertion/deletion mutations within the variable regions. The new polymorphic sites are
then perturbed as in δNuc, with the addition of gap as a fifth type of ‘nucleotide’.

2.2.3. In silico simulation of recombination events
Five hundred VlsE variants were generated from the natural unexpressed cassettes from
each of the seven Borrelia genotypes analyzed, as well as from each of the in silicoperturbed sets of unexpressed cassettes. Each VlsE variant was generated by simulating
one recombination event between the unexpressed cassettes and the natural vlsE sequence.
For each recombination event, a segment was selected at random from the set of
unexpressed cassettes and used to replace the homologous segment in the vlsE sequence
observed in the natural strain. The length of the selected segment was chosen at random
from an even distribution between 2 to 200bp. The range and distribution of segment
lengths was derived from lengths of recombining fragments observed in Bb strains
infecting laboratory mice [20].
2.2.4. Sequence divergence, translational ability, and translational efficiency of VlsE
variants
We evaluated sequence divergence, translational ability, and translational efficiency of
each of the VlsE variants generated from the in silico recombination events from each of
the natural and perturbed unexpressed cassette.
2.2.4.1. Estimation of sequence divergence

16

Amino acid sequence divergence is correlated with antigenic divergence [25, 46, 47].
Amino acid sequence divergence between the in silico-generated VlsE variant and the
natural VlsE sequence was estimated by calculating the ratio of non-identical amino acids
in the alignment of the two sequences (amino acid weight matrix=GONNET, gap
opening penalty=10, gap extension penalty=0.1).
2.2.4.2. Estimation of translational ability
Translational ability was defined as sequences that do not encode premature stop codons
or frameshifts that are not corrected prior to the terminal stop codon. vlsE sequences that
contained either premature stop codons or an unreverted frameshift had zero translational
ability while those that could produce a complete protein had translational ability equal to
one.
2.2.4.3. Estimation of translational efficiency
Although translational efficiency is determined by multiple factors, variations in
elongation rate among VlsE variants may be especially important in the translational
efficiency of this highly expressed protein because the recombination mechanism does
not alter the 5’ or 3’ sequences of the expression site and thus does not alter initiation and
termination rates [18]. Codons with more abundant tRNAs are likely to be translated with
a greater elongation rate and with greater accuracy [40]. Thus, optimality of codon usage
with respect to tRNA abundance was used as a proxy for translational efficiency. Codon
optimality was estimated using two statistics, average tRNA copy number and tRNA
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adaptation index, both of which have been shown to correlate with tRNA abundance [4851] and codon decoding rate in many prokaryotes [52].
tRNA copy number, E(T), was estimated as the number of copies of tRNA genes that pair
to a codon, averaged over all codons in the vlsE sequence:
𝑛𝑛

1
E(T) = � 𝑇𝑇𝑖𝑖
𝑛𝑛
𝑖𝑖=1

where n is the total number of codons in a vlsE variant, Ti is the number of copies of
tRNA genes in the genome that pair with the ith codon [53].
tRNA adaptation index, tAI, was calculated according to dos Reis et al [52]. First, the
absolute adaptiveness value Wi for the ith codon was calculated:
𝐼𝐼𝑖𝑖

Wi = �(1 − 𝑆𝑆𝑖𝑖𝑖𝑖 )𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑖𝑖𝑖𝑖
𝑗𝑗=1

where Ii is the total number of tRNA isotypes that pair with the ith codon, tGCNij is the
numer of copies of the jth tRNA isotype genes in the genome that pair with the ith
codon, and Sij is a selective constraint on the efficiency of the codon–anticodon
coupling. Second, the relative adaptiveness value wi of the ith codon was calculated:
𝑤𝑤𝑤𝑤 = �

𝑊𝑊𝑖𝑖 /𝑊𝑊𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 𝑖𝑖𝑖𝑖 𝑊𝑊𝑊𝑊 ≠ 0
𝑤𝑤𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚
𝑖𝑖𝑖𝑖 𝑊𝑊𝑊𝑊 = 0

where Wmax is the maximum Wi value and wmean is the geometric mean of
all wi with Wi ≠ 0. Finally, tAI was calculated as the geometric mean of the relative
adaptiveness values of all codons in a vlsE variant:
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𝑛𝑛

tAI = (� 𝑤𝑤𝑖𝑖 )1/𝑛𝑛
𝑖𝑖=1

where n is the total number of codons in a vlsE variant.

2.3. Results
2.3.1. Effect of altering the nucleotide identities observed in the variable sites
The maximum-likelihood stationary distribution of the four types of nucleotides was
estimated at the unexpressed cassettes in each of the seven Borrelia genotypes
respectively. The maximum likelihood stationary distributions of nucleotides were not
significantly different from the observed distribution of nucleotides in the unexpressed
cassettes of any of the seven genotypes (Table 2-2).
The nucleotide identities observed in variable sites of the unexpressed cassettes of natural
strains result in the greatest sequence divergence, translational ability, and translational
efficiency in VlsE variants. Changing nucleotides at the sites that are naturally
polymorphic among the unexpressed cassettes (δNuc) reduced the sequence divergence
among VlsE variants as well as the translational ability and translational efficiency of the
variants (Figure 2-2). The reduction in sequence divergence, translational ability, tRNA
gene copy number and tRNA adaptation index due to nucleotide alterations were
statistically significant (p<0.05) in all genotypes except for tRNA gene copy number in
BoI26 and tRNA adaptation index in 29805 when nucleotides are sampled from the
maximum likelihood stationary distribution, as well as tRNA adaptation index in 29805
and zs7 when nucleotide types are sampled from a uniform distribution.
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Frequency A

Frequency T

Frequency G

Frequency C

p (chi-square)

B31 (ML)

0.25174

0.24123

0.40096

0.10607

>0.99

B31 (OB)

0.26222

0.23898

0.38755

0.11125

JD1 (ML)

0.26558

0.24924

0.37682

0.10836

JD1 (OB)

0.26032

0.25714

0.37490

0.10764

WI9123 (ML)

0.29318

0.21727

0.38468

0.10487

WI9123 (OB)

0.27846

0.22986

0.38887

0.10281

29805 (ML)

0.21181

0.28739

0.38064

0.12016

29805 (OB)

0.21976

0.27708

0.37411

0.12905

Bol26 (ML)

0.24390

0.27059

0.37647

0.10904

Bol26 (OB)

0.23457

0.27132

0.37353

0.12059

Zs7 (ML)

0.25265

0.23737

0.39438

0.11559

Zs7 (OB)

0.26279

0.23704

0.38718

0.11299

B. afzelii (ML)

0.25697

0.24668

0.38509

0.11125

B. afzelii (OB)

0.23912

0.26598

0.38075

0.11415

>0.99

>0.99

0.98

0.99

0.99

0.96

Table 2-2. Maximum likelihood (ML) and observed (OB) nucleotide frequencies at the
vls loci in seven genotypes of Borrelia used in the study
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Figure 2-2. Changes in sequence divergence, translational ability, tRNA gene copy
number and tRNA adaptation index of VlsE variants after altering the identities of the
variable nucleotides in unexpressed cassettes (δNuc). The y-axis shows difference in
sequence divergence (A1, A2), translational ability (B1, B2), tRNA gene copy number
(C1, C2) and tRNA adaptation index (D1, D2) from the values of VlsE variants generated
by the natural unexpressed cassettes after perturbing the variable nucleotides by sampling
nucleotides randomly (A1, B1, C1, D1) or from a maximum-likelihood stationary
distribution (A2, B2, C2, D2). Negative values on the y- axis mean a reduction after
perturbation; zero means no change after perturbation. Each datapoint corresponds to the
mean of 500 vlsE variants generated from one iteration of the perturbation model. Error
bars represent 95% confidence intervals of the mean.

2.3.2. Effect of altering the positions of the variable sites
Altering the positions of the variable sites in the variable regions of the cassettes (δPos)
resulted in a reduction in the translatability and translational efficiency of VlsE variants
compared to the VlsE variants generated from the natural unexpressed cassettes in all
analyzed strains (Figure 2-3B1, 2-3B2, 2-3C1 and 2-3C2). However, regardless of how
the nucleotides were sampled to generate the perturbed cassettes, the translational ability
of VlsE variants produced from the cassettes with altered variable locations was
significantly lower than VlsE variants produced from cassettes with altered nucleotides
(δNuc) in only two of the seven genotypes (WI9123 and Bol26), tRNA gene copy
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number was significantly lower in only two of the seven genotypes (29805 and B. afzelii)
and tRNA adaptation index was significantly lower in five of the seven genotypes (B31,
JD1, 29805, BoI26 and B. afzelii) (Figure 2-2B1, 2-2B2, 2-2C1, 2-2C2, 2-3B1, 2-3B2, 23C1, 2-3C2). Thus, it is not apparent that altering the positions of the variable sites
compounds the reduction in translational ability and efficiency of VlsE variants caused
by altering the nucleotides alone. It is important to note that altering the positions of the
variable sites must be accompanied by alterations in nucleotides, resulting in a reduction
in power to detect effects of the position of the variable sites on translational ability and
translational efficiency of VlsE variants independent of the large effect of nucleotide
identity.
Sequence divergence among VlsE variants generated from the unexpressed cassettes with
computationally altered positions of variable sites (δPos) was significantly lower than the
variants produced by the natural cassettes in five of the seven strains (B31, JD1, 29805,
zs7 and B. afzelii) (Figure 2-3A1 and 2-3A2). However, the divergence among VlsE
variants generated from cassettes with positionally altered variable sites (δPos) was
significantly lower than the difference produced from altering the nucleotide type (δNuc)
in none of the seven genotypes (Figure 2-2A1, 2-2A2, 2-3A1 and 2-3A2). Thus, altering
the positions of the variable sites does not cause a greater reduction in sequence
divergence than altering the nucleotide identities alone. Further, alteration of the position
of variable sites in one genotype (Bol26) resulted in a significantly greater sequence
difference of the VlsE variants than the variants produced from the natural cassettes.
Although the potential for VlsE variant diversity was significantly elevated by altering
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the positions of the variable sites in this strain, the sequences in the expression site that
resulted from these recombination events had low translational ability and efficiency
(Figure 2-3B1, 2-3B2, 2-3C1 and 2-3C2) which are likely to constrain changes in the
location of the variable sites.
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Figure 2-3. Changes in sequence divergence, translational ability, tRNA gene copy
number and tRNA adaptation index of VlsE variants after altering the positions of the
variable sites in unexpressed cassettes (δPos). The y-axis shows difference in sequence
divergence (A1, A2), translational ability (B1, B2), tRNA gene copy number (C1, C2)
and tRNA adaptation index (D1, D2) from the values of VlsE variants generated by the
natural unexpressed cassettes after perturbing the positions of the variable sites.
Nucleotides at the relocated variable sites were sampled randomly (A1, B1, C1, D1) or
from a maximum-likelihood stationary distribution (A2, B2, C2, D2). Negative values on
the y- axis mean a reduction after perturbation; zero means no change after perturbation.
Each datapoint corresponds to the mean of 500 vlsE variants generated from one iteration
of the perturbation model. Error bars represent 95% confidence intervals of the mean.

2.3.3. Effect of altering the locations of insertion/deletion mutations
The locations of insertion/deletion mutations strongly affect the translational ability of
VlsE variants. Altering the location of all variable sites, including those with
insertion/deletion variants, significantly decreases translational ability compared to both
the VlsE variants produced by the natural cassettes and the variants produced by cassettes
with altered locations of variable sites (δPos) (Figure 2-3B1, 2-3B2 and 2-4B). The
decreases in translational ability are dramatic, with as many as half of the variants
containing at least one stop codon (Figure 2-4B). The VlsE variants also show
significantly lower sequence divergence and lower translational efficiency than those
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generated by the natural unexpressed cassettes in all strains (Figure 2-4A and 2-4C).
These results indicate that the patterns of insertion/deletion occurrence are strongly
constrained by sequence divergence, translational efficiency, and especially translational
ability.

Figure 2-4. Changes in sequence divergence, translational ability, tRNA gene copy
number and tRNA adaptation index of VlsE variants after perturbing the
insertion/deletion mutations in unexpressed cassettes (δInDel). The y-axis shows
difference in sequence divergence (A), translational ability (B), tRNA gene copy number
(C) and tRNA adaptation index (D) from the values of VlsE variants generated by the
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natural unexpressed cassettes after perturbing the insertion/deletion mutations. Negative
values on the y- axis means a reduction after perturbation; zero means no change after
perturbation. Each datapoint corresponds to the mean of 500 vlsE variants generated from
one iteration of the perturbation model. Error bars represent 95% confidence intervals of
the mean.

2.4. Discussion
Antigenic variation systems experience strong selection to evade the rapidly changing
and lethal host immune environment. Thus, there is a premium for ever greater antigenic
divergence among protein variants generated by antigenic variation systems. However,
divergence among antigenic variants as well as the organization of the antigenic variation
system as a whole can be constrained by selection for basic molecular functions such as
translational ability or translational efficiency. The computational analyses presented here
demonstrate that the vls antigenic variation system that generates antigenic diversity in
natural strains of Bb during infections of vertebrate hosts is shaped by forces of natural
selection acting on greater antigenic divergence, translational ability, and translational
efficiency.
Bb strains generate antigenically distinct protein variants by recombining segments of
diverse, homologous, unexpressed cassettes into the expression site of the antigen. In all
natural strains analyzed, the sequence divergence among expressed proteins, as well as
the translational ability and translational efficiency of those proteins, is highest by using
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the nucleotides observed at the sites that are variable among the unexpressed cassettes.
Altering the nucleotides used at these sites can reduce the sequence divergence, introduce
stop codons, and reduce the elongation rate by using non-preferred codons. Although
many of the Bb genomic codons are chosen because of mutational biases or replicational
selection and are not optimized for translation [54], our results show that codon usage in
vlsE is selected for translational efficiency. Codon optimality may be particularly
important to the elongation rates and translational accuracy of VlsE variants as there are
many variable codons that are tandemly arrayed in the unexpressed cassettes. Tandem
codons using non-preferred codons can act synergistically to reduce translational rate and
accuracy [55, 56]. A hypothesized function of the VlsE protein, to protect other surfaceexposed proteins from antibodies by hiding these potential antigens [21], requires highly
expressed and accurately translated proteins for appropriate antigenicity. It is worth
noting that, although the statistical difference in codon optimality between natural and
perturbed cassettes is consistent across Bb strains, the quantitative influence of such
difference on VlsE concentration is not tested and beyond the scope of this thesis. Future
analysis in the translational dynamics of VlsE may shed light on this question.
Altering the position of the variable sites within the variable regions significantly reduced
both the translational ability and translational efficiency of VlsE variants generated. The
sequence divergence of VlsE variants generated from positionally altered cassettes,
however, was significantly lower than that from the natural cassettes in only five of the
seven strains. Further, divergence among the VlsE variants generated after altering the
positions of the variable sites in one strain (Bol26) was significantly greater than those
generated from the natural cassettes. Strain BoI26 is a unique case where many codons
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contained multiple variable nucleotides. These variable sites become separated on
different codons after positional perturbation, leading to greater amino-acid-level
divergence after recombination.
The organization and identity of variable sites in the unexpressed cassettes of natural
strains resulted in high amino acid divergence among the VlsE variants, suggesting that
the sequences of the unexpressed cassettes observed in natural strains strongly promotes
antigenic divergence. Amino acid sequence difference among antigens is negatively
correlated with cross-reactivity with polyclonal antibodies [25, 46, 47]. This reduction in
binding affinity to antibodies is crucial for immune evasion and longevity of Bb in
infected hosts, a key factor in the fitness of Bb. Although altering the positions of variable
sites in one strain (Bol26) increases sequence differences of the VlsE variants, which may
provide greater ability to evade the immune response, many of these VlsE variants
contained stop codons, frameshifts, and low translational efficiency. Therefore, the
potential advantage of greater antigenic diversity is likely constrained by selection for
efficient expression of functional proteins.
Perturbing both nucleotide identities and the positions of variable sites did not result in a
greater reduction in antigenic divergence, translational ability, and translational efficiency
of VlsE variants than altering only the nucleotide identities. Although the positions of the
variable sites in the unexpressed cassettes may be selectively important, the absence of an
observed effect may be attributed to two factors. First, the positions of variable sites
cannot be altered without also altering the nucleotides at those positions. Thus, the effect
of the position of the variable sites cannot be disentangled from the effects of nucleotide
identities at these sites, resulting in low statistical power to detect the effect of the
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variable positions. Second, the positions of variable sites might be important for traits
that were not evaluated. For example, amino acids at the positions that are naturally
variable may be more antigenic than those at other positions or may impact the three
dimensional structure of VlsE.
Length differences among unexpressed cassettes occur almost exclusively in triplets in all
natural strains, resulting in very low levels of frameshift mutations during recombination.
The triplet pattern of insertion/deletion mutations may result from slipped-strand
mispairing induced by trinucleotide repeats that are common in the variable regions of all
strains [27]. The δInDel algorithm, however, randomized the locations of
insertion/deletion mutations, disrupting the triplets and dramatically increasing the rate of
frameshift mutations in the VlsE variants. These frameshift mutations result in a large
number of premature stop codons in vlsE. This observation is consistent with the
hypothesis that natural selection can increase off-frame stop codons because they prevent
resource waste and potentially cytotoxic products when frameshifts occur [57].
In recombination-based antigenic variation systems, the genetic sequences of the
unexpressed cassettes determine the possible degree of diversity among antigenic variants
during a host infection. The analyses presented in this chapter demonstrate that the vls
antigenic variation systems of Bb is organized to promote antigenic divergence among
proteins variants without significantly sacrificing translational ability and translational
efficiency. The selection on translational properties in unexpressed regions was
statistically significant and in some cases appeared to constrain the selection for greater
antigenic diversity. These analyses identified properties of the antigenic variation system
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that appear to be under selective constraints which can be experimentally investigated in
future studies. The selection pressures described here could be common in the diverse
range of pathogens that generate antigenic variants by intragenomic recombination such
as Neisseria gonorrhoeae and Mycoplasma synoviae [34, 35]. In these pathogens, similar
computational analyses to those conducted in this study can be used to establish the sets
of selection pressures that affect the evolution of unexpressed cassettes.
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Chapter 3. Predicted effects of VlsE diversity on Borrelia
burgdorferi dynamics within hosts
3.1. Introduction
Lyme disease is the most commonly reported tick-borne illness in North America. The
causative agent, Borrelia burgdorferi (Bb), establishes long-term, multisystemic
infections despite active adaptive immune responses from vertebrate hosts [18, 58]. Bb
evades host immune responses through multiple mechanisms including the vital and wellcharacterized vls antigenic variation system [18]. The vls antigenic variation system alters
the sequence of the immunodominant surface-exposed antigen, VlsE, resulting in VlsE
sequence diversity within hosts [18, 19]. Subpopulations of Bb with altered VlsE
sequences evade antibody recognition, thus permitting the characteristic long-term
infections [18, 22-24, 38, 39]. The quantitative effect of the generation of VlsE diversity on
the probability of immune evasion or on Bb population sizes within hosts has not been
investigated.
The within-host population dynamics of Bb are controlled by the adaptive immune
response. In immunocompetent mice, Bb rapidly proliferates in the initial phases of the
infection before inducing a strong antibody response against several surface exposed
proteins [59], predominantly VlsE, around day 7 of the infection, leading to a rapid
reduction in abundance [60]. Yet, Bb is rarely cleared in immunocompetent mice likely
due to the down regulation of most surface exposed antigens and the antigenic variation
generated at VlsE [18, 60]. The degree of diversity among VlsE variants expressed in the
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Bb population is expected to be essential to avoiding clearance by the antibody response
of the host [20, 27]. Evolutionary studies demonstrated that natural selection selects for
greater potential to generate diversity at VlsE and that the variable sites within the
cassettes are organized to maximize diversity among VlsE variants [27, 61]. Yet it
remains unclear how the diversity among VlsE variants facilitates within-host persistence
or affects Bb population dynamics within hosts.
In this study, we investigated the effects of antigenic diversity at VlsE on the population
dynamics of Bb within infected hosts. The population dynamic models were
parameterized using relevant experimental data and the results were compared to data on
Bb population dynamics of Bb from experimental infections. Importantly, we compared
the effect of a strain’s ability to generate diversity at VlsE on the population dynamics of
the pathogen. In addition, the models make predictions that can be experimentally tested
to estimate the likelihood of mechanisms described in the models.

3.2. Materials and Methods
3.2.1. Dynamic model
The dynamic model used to assess Bb population dynamics incorporates the presence and
abundance of each VlsE variant as well as the specificities, affinities and abundances of
antibodies. Bb population dynamics - including growth, recombination and immune
clearance - are described by:
𝑑𝑑𝑑𝑑𝑑𝑑(𝑖𝑖)
𝑑𝑑𝑑𝑑

= 𝜔𝜔𝜔𝜔𝐵𝐵𝐵𝐵(𝑖𝑖) �1 −

𝑑𝑑𝐵𝐵𝐵𝐵∗ (𝑖𝑖)
𝑑𝑑𝑑𝑑

∑𝑖𝑖 𝐵𝐵𝐵𝐵(𝑖𝑖)
𝐾𝐾

� − 𝑟𝑟𝑟𝑟𝑟𝑟(𝑖𝑖) − 𝜇𝜇 × 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴(𝑖𝑖)𝐵𝐵𝐵𝐵(𝑖𝑖) + 𝜈𝜈𝐵𝐵𝐵𝐵 ∗ (𝑖𝑖)

= 𝜇𝜇 × 𝐴𝐴𝐴𝐴rxn(𝑖𝑖)𝐵𝐵𝐵𝐵(𝑖𝑖) − 𝜈𝜈𝐵𝐵𝐵𝐵 ∗ (𝑖𝑖) − 𝑟𝑟𝐵𝐵𝐵𝐵 ∗ (𝑖𝑖) − 𝜌𝜌𝐵𝐵𝐵𝐵 ∗ (𝑖𝑖)
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eq. 3.1

eq. 3.2

Such that Bb expressing VlsE variant type i (Bb(i)) grows logistically with an intrinsic
growth rate β. Antibody-independent immune effects are described as an adjustment in
the growth rate by a factor ω. A carrying capacity K for the Bb population is estimated
from in vitro growth data [62]. Bb(i) recombines with the unexpressed vls cassettes at rate
r. Bb(i) interacts with antibodies at association rate μ. Abrxn(i) represents the binding
capacity of all antibodies present in the system to Bb(i) and is a function of the
concentration of each type of antibody, corrected by the specificity of that antibody for
the VlsE variant, summed across all antibodies present (detailed in 3.2.1.3). Bb(i)
transitions to the susceptible state Bb*(i) when bound by an antibody, which is then
removed by the immune system at constant rate ρ. Bb*(i) can dissociate from antibodies
at rate ν.
3.2.1.1 Antigenic variation by recombination
Bb infecting immunocompetent mice remain at densities much lower than the carrying
capacity due to the host antibody responses [60]. However, Bb are not eliminated due to
the sequence changes in VlsE introduced by recombination, which reduces antibody
killing efficacy. Pairwise sequence similarity between VlsE variants is expected to be a
function of the sequence diversity among the vls cassettes that recombine into vlsE and
the number of recombination events that have occurred since the variants shared a
common ancestor. We estimated the distribution of pairwise sequence similarities
between VlsE variants by simulating recombination between vls cassettes and VlsE. To
do this, we first generated 1000 vlsE parental variants (vlsEn). Each parental variant was
generated by simulating 100 sequential recombination events starting from the vlsE
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sequence of Bb clone 5A3, as described in Chapter 2.2.3. From each of the 1000 parental
vlsEn sequences, we simulated 20 daughter sequences (vlsE1n-vlsE20n) that experienced
between 1 and 20 recombination events in order to estimate sequence similarity between
vlsE variants as a function of the number of recombination events (Dr). Pairwise
sequence similarity between each VlsEn and each of its daughter sequences (VlsE1nVlsE20n) was calculated as amino acid sequence identity. The expectation (M(Dr)) and
variance (𝜎𝜎(Dr)) in sequence similarities between VlsE variants separated by Dr
recombination events was calculated as the mean and standard deviation of the 1000
sequence similarity values for each value of Dr.
Two sets of vls unexpressed cassettes were used to estimate the distribution of pairwise
sequence similarities between VlsE variants: the natural vls unexpressed cassettes
observed in Bb clone 5A3 and a set of unexpressed cassettes generated in silico by
altering the nucleotides at the variable sites as described in 2.2.2.1. The in silico
generated unexpressed cassettes produces VlsE variants with lower diversity than the
natural unexpressed cassettes.
3.2.1.1.2. Sequence similarities among VlsE variants within infections
In the model of Bb population dynamics, recombination between vlsE and the
unexpressed vls cassettes results in a novel vlsE variant, similar to an infinite alleles
model. Each new vlsE variant can be represented by a node in a tree graph, connected to
its direct parental vlsE by one edge. The number of recombination events (Dr) between
VlsE variants i and j is equivalent to the number of edges connecting the nodes
36

representing variants i and j. For VlsE variants i and j that are separated by over 20
recombination events, Dr is set to 20. This approximation utilizes the diminishing effect
of recombination events (Dr) on sequence similarity (section 3.3.5). Sequence similarities
between VlsE variant type i and j (S(i,j)) within an infection are determined by sampling
from the distribution of pairwise sequence similarities conditional on Dr:

𝑃𝑃(𝑆𝑆(𝑖𝑖, 𝑗𝑗)|𝐷𝐷𝐷𝐷) = 𝑁𝑁(𝛭𝛭(𝐷𝐷𝐷𝐷), 𝜎𝜎(𝐷𝐷𝐷𝐷)

2)

=

1

𝜎𝜎 √2𝜋𝜋

𝑒𝑒

−(𝑆𝑆(𝑖𝑖,𝑗𝑗)−𝛭𝛭(𝐷𝐷𝐷𝐷))2
2𝜎𝜎(𝐷𝐷𝐷𝐷)2

eq. 3.3

The sequence similarities among variants created by recombination are relevant to the
degree of reactivity of antibodies specific to variant i have for variant j.
3.2.1.2 Antibody kinetics
The concentration of antibodies targeting VlsE variants was modeled similar to
Michaelis-Menten kinetics [62, 63]. Antibodies specifically targeting VlsE variant type i
are triggered when the abundance of the Bb(i) subpopulation is greater than 1000
individuals. The magnitude of the antibody response that is specific to VlsE type i
(Abspecific(t,i)) is estimated by:
0

𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴(𝑡𝑡, 𝑖𝑖) = �𝐴𝐴𝐴𝐴

𝑛𝑛
𝑚𝑚𝑚𝑚𝑚𝑚 ( 𝑡𝑡−𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 −𝛥𝛥𝑡𝑡lag )
2 +(𝑡𝑡− 𝑡𝑡
𝑛𝑛
𝑡𝑡1/2
𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 −𝛥𝛥𝑡𝑡lag )

𝑡𝑡 − 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 < 𝛥𝛥𝑡𝑡𝑙𝑙𝑙𝑙𝑙𝑙

𝑡𝑡 − 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 > 𝛥𝛥𝑡𝑡lag

eq. 3.5

When ∑𝑖𝑖 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴(𝑡𝑡, 𝑖𝑖) ≤ 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴

Where ttrig is the time when the antibody specific to variant type i is triggered. If the sum
of the concentrations of all antibody types exceeds the experimentally observed
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maximum antibody concentration (Abmax) [63, 64], the concentration of each antibody
type was normalized to Abmax.
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴(𝑡𝑡,𝑖𝑖)

𝐴𝐴𝐴𝐴𝑠𝑠𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝(𝑡𝑡, 𝑖𝑖) = 𝐴𝐴𝐴𝐴(𝑡𝑡) ∑

eq. 3.6

𝑖𝑖 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴(𝑡𝑡,𝑖𝑖)

When ∑𝑖𝑖 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴(𝑡𝑡, 𝑖𝑖) > 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴

3.2.1.2.1 Immunodominant antibody kinetics
A potential constraint on antibody dynamics is the number of types of antibodies that can
be induced per unit of time. Although the naïve antibody repertoire is highly
heterogeneous, only a small subset of the B cell clones will proliferate significantly
during an infection - a well-characterized phenomenon called antibody
immunodominance [25, 65]. We extended the dynamics model to include antibody
immunodominance to account for this constraint. For the sake of simplicity, we allowed
only one immunodominant antibody type to be actively produced at a given time. The
type of antibody that was activated was chosen based on the relative abundance of the
corresponding VlsE variant.
Each dominant antibody is actively produced for Td hours before the next type of
dominant antibody was allowed to expand, eventually replacing the previous dominant
antibody. The dynamics of each type of dominant antibody was described by:

𝐴𝐴𝐴𝐴𝑠𝑠𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝j (𝑡𝑡, 𝑖𝑖) =

⎧
⎪

0

𝐴𝐴𝐴𝐴𝑚𝑚𝑚𝑚𝑚𝑚 ( 𝑡𝑡−𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 −𝛥𝛥𝑡𝑡la𝑔𝑔 )𝑛𝑛

𝑡𝑡 − 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 < 𝛥𝛥𝑡𝑡la𝑔𝑔

𝛥𝛥𝑡𝑡𝑙𝑙𝑙𝑙𝑙𝑙 ≤ 𝑡𝑡 − 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 < 𝑇𝑇𝑇𝑇

2
𝑡𝑡1/2
+(𝑡𝑡− 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 −𝛥𝛥𝑡𝑡la𝑔𝑔 )𝑛𝑛

⎨ 𝐴𝐴𝐴𝐴𝑚𝑚𝑚𝑚𝑚𝑚 ( 𝑡𝑡−𝛥𝛥𝑡𝑡la𝑔𝑔 )𝑛𝑛
⎪ 2
− 𝐴𝐴𝐴𝐴𝑠𝑠𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑗𝑗+1 (𝑡𝑡, 𝑖𝑖)
⎩ 𝑡𝑡1/2 +(𝑡𝑡−𝛥𝛥𝑡𝑡la𝑔𝑔 )𝑛𝑛
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𝑡𝑡 − 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 ≥ 𝑇𝑇𝑇𝑇

eq. 3.11

Where Abspecificj represents the concentration of the jth activated immunodominant
antibody.
3.2.1.3 Antibody effects on Bb dynamics
Specific and non-specific but cross-reactive antibodies negatively impact the abundance
of Bb. The quantitative impact of antibodies specific to VlsE variant j on the dynamics of
Bb expressing VlsE variant i is a function of the abundance of antibody j (Abspecific(t,j))
and the degree of cross-reactivity between antibody j and VlsE variant i (f(S(i,j))). The
degree of cross reactivity between antibody j and VlsE variant i is dependent on the
similarity between VlsE types i and j:
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴(𝑡𝑡, 𝑖𝑖) = ∑𝑗𝑗 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴(𝑡𝑡, 𝑗𝑗) 𝑓𝑓(𝑆𝑆(𝑖𝑖, 𝑗𝑗))

eq. 3.7

Where 𝑓𝑓(𝑆𝑆(𝑖𝑖, 𝑗𝑗)) is a function that modulates antibody reactivity via the sequence

similarity between the VlsE variants i and j. By definition, this function should satisfy
f(1)=1 and f(0)=0. For simplicity, cross-reactivity is modeled using a power function.
𝑓𝑓�𝑆𝑆(𝑖𝑖, 𝑗𝑗)� = 𝑆𝑆(𝑖𝑖, 𝑗𝑗)𝑥𝑥

eq. 3.8

Where larger values of x correspond to higher antibody specificity and lower crossreactivity.
3.2.1.4 The immune effector cells
The rate at which antibody-bound Bb cells are eliminated depends on the concentration
of immune effector cells such as phagocytes [62]. Therefore, population dynamics of
immune effector cells may also affect Bb population dynamics. Immune effector cell
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dynamics are modeled similarly to Binder et al [62]. Immune effector cells are assumed
to behave qualitatively similar to phagocytes in the sense that they have an intrinsic
migration rate, a recruitment rate in response to the presence of antigens, and an intrinsic
death rate:
𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑

𝜓𝜓 ∑𝑖𝑖(𝐵𝐵𝐵𝐵(𝑖𝑖)+𝐵𝐵𝐵𝐵∗ (𝑖𝑖))

= 𝜙𝜙 + ∑

𝑖𝑖(𝐵𝐵𝐵𝐵(𝑖𝑖)+𝐵𝐵𝐵𝐵

∗ (𝑖𝑖))+𝐶𝐶

𝑀𝑀 − 𝜃𝜃𝜃𝜃

eq. 3.9

Where 𝜙𝜙 is the intrinsic rate of recruitment of immune effectors to an infection sites; 𝜓𝜓 is
the recruitment rate of immune effectors in response to infection; 𝜃𝜃 is the death rate of
the immune effectors; and C is the number of Bb that corresponds to half maximum
recruitment rate.
When immune effector cell dynamics are included in the model, eq. 3.2 becomes:
𝑑𝑑𝐵𝐵𝐵𝐵∗ (𝑖𝑖)
𝑑𝑑𝑑𝑑

= 𝜇𝜇 × 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴(𝑖𝑖)𝐵𝐵𝐵𝐵(𝑖𝑖) − 𝜈𝜈𝐵𝐵𝐵𝐵 ∗ (𝑖𝑖) − 𝑟𝑟𝐵𝐵𝐵𝐵 ∗ (𝑖𝑖) − 𝜌𝜌0 𝐵𝐵𝐵𝐵 ∗ (𝑖𝑖)𝑀𝑀

eq. 3.10

Where the rate of removal of the antibody-bound Bb follows the law of mass action.
3.2.2. Numerical simulation based on the dynamics model
Bb population dynamics were simulated numerically to allow stochastic events to impact
the qualitative and quantitative outcomes of the system. Parameter values used in
numerical simulation were estimated based on literature or by fitting experimental
observations to minimize the sum of squared errors between observations and predictions.
The numerical simulation was repeated 20 times with each set of parameter values.
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3.3. Results
3.3.1. Bb dynamics cannot be explained by the dynamics model without including
antibody immunodominance or dynamics of immune effector cells
Regardless of the parameters used, the Bb population dynamics observed in experimental
infections could not be replicated using the simple population dynamic model that does
not explicitly account for either antibody immunodominance or for immune effector cell
dynamics. Simulations across the simple model using either low removal rates of
antibody-coated Bb (ρ) or high antibody specificity (x) permitted persistent infections but
the dramatic decline in Bb population densities observed in experimental infections after
the initial proliferation could not be reproduced (Figure 3-1). By contrast, high removal
rates or low antibody specificity recreated the rapid decrease in population densities after
the initial proliferation but populations were consistently eliminated from the host (Figure
3-1). Parameter values used for numerical simulation are listed in Table 3-1.
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Figure 3-1. Numerical simulations of the Bb population dynamic models that did not
include antibody immunodominance nor immune effector cell dynamics could not
reproduce experimental time series of Bb population dynamics in mice. Bb population
dynamics are simulated with different values of the removal rate (ρ) and antibody
specificity (x). Open circle, Bb levels experimentally observed by Pahl et al. [60].
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Parameter

Unit

Value

Derived from

Description

β

hour−1

0.06

[66]

Bacterial growth rate

K

cells

150000

[60]

Bacterial carrying capacity

𝜌𝜌0
Abmax

cells−1 hour−1
μg ml−1

0.0082
8.5

[62]
[59]

ω

-

0.9

Estimated

r
µ
𝜈𝜈

hour−1
ml μg−1 hour−1
hour−1

0.0059
0.0085
1

[20]
[62]
[62]

Immune effector cells killing rate
Maximum total antibody
concentration
Decrease in bacterial growth rate
due to Innate immune effect
Recombination rate
Antibody association rate
Antibody dissociation rate

𝛥𝛥𝑡𝑡𝑙𝑙𝑙𝑙𝑙𝑙
x

hour
-

72
7.5(immune effector
dynamics)
2.25(antibody
immunodominance)

[63]
Estimated

Time until antibody response starts
Antibody specificity

𝜙𝜙

cells hour−1

0.1

[62]

𝜓𝜓

hour−1

0.025

Estimated

𝐶𝐶

cells

35000

Estimated

𝜃𝜃
𝑇𝑇𝑇𝑇

hour−1
hour

0.08
360

[67]
Arbitrary

Intrinsic recruitment rate of
immune effector cells
Bb-dependent recruitment rate of
immune effector cells
Bb population size that yields halfmaximal recruitment of immune
effector cells
Immune effector cells death rate
Time when one type of antibody is
dominantly expressed

Table 3-1. Parameters used in the numerical simulations.
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3.3.3. Including antibody immunodominance in the model can account for
experimentally observed Bb population dynamics within hosts
The Bb dynamics observed in experimentally infected mice can be reproduced by
including immunodominance - where only one type of antibody is actively expressed at a
time - into the population dynamic model (Table 3-1). Bb populations rapidly increase in
density followed by a dramatic decline caused by antibodies specific to the parental VlsE
variant (Figure 3-2A). However, a sufficient number of recombinant VlsE variants are
different enough from the parental VlsE to allow continued persistence in the host,
similar to the observed data. The relative abundance of Bb cells expressing the parental
VlsE decreased rapidly following the specific antibody response as was observed in
experimentally infected mice (Figure 3-2B). The predicted Bb population dynamics and
VlsE variant dynamics that most closely resembled the empirical data from experimental
infections assumed that antibody specificity was related to sequence diversity as
𝑆𝑆(𝑖𝑖, 𝑗𝑗)2.25 (Table 3-1).
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Figure 3-2. Numerical simulation of Bb population dynamics with antibody
immunodominance included in the model can reproduce the experimental time series. (A)
The Bb population dynamics predicted by the model that includes antibody
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immunodominance replicates the data from experimental infections. Open circle, Bb
levels experimentally observed by Pahl et al. [60]. (B) Additionally, the proportion of Bb
cells retaining the parental VlsE sequences predicted by the numerical simulation was
similar to the proportion retaining the parental sequence in experimental infections
observed by Coutte et al. [20] in C3H mice (open circles).

The mean antibody pressure (Abrxn) across extant VlsE variants differed considerably
between the models that included and excluded immunodominance (Figure 3-3). In the
models including antibody immunodominance, the average antibody pressure increased
each time a new type of antibody was generated and declined thereafter as the proportion
of specific variants declined (Figure 3-3 A), demonstrating a fluctuating and dynamic
effect on the Bb population. The immunodominant antibody has high affinity to one VlsE
variant, which is rapidly removed from the population, and distinct affinities to the other
VlsE variants, resulting in a much larger variance in antibody pressure among VlsE types
than in models that allow multiple antibodies, each with affinities to different VlsE types,
simultaneously (Figure 3-3B). Antibody pressure in models that excluded
immunodominance was remained stable after the initial increase (Figure 3-3A).
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Figure 3-3. Antibody immunodominance creates temporal variation in antibody pressure
(𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴) on Bb within hosts. (A) The mean antibody pressure across all extant VlsE
variants increases rapidly after the first antibody is expressed (arrow at day 3) in all
models. If antibody immunodominance is not included, the mean antibody pressure
remains constant while new antibodies are continuously added. Including
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immunodominance results in declining mean antibody pressure until the expansion of a
subsequent antibody (arrow at day 18) causes the mean antibody pressure to increase. (B)
The difference in the standard deviation in antibody pressure across the extant VlsE
variants between models that include immunodominance and those that do not is
dramatic. In models that include immunodominance, variance in antibody pressure
increases rapidly as the dominant antibody targeting the dominant VlsE variant
proliferates, then decreases due to the reduction in the density of the dominant VlsE
variant until the introduction of the subsequent antibody. In models that exclude
immunodominance, there are many antibodies that each react with each extant VlsE
variant, such that each VlsE variant experience similar antibody pressure.

3.3.4. Models including immune effector cell dynamics can reproduce the
experimentally observed Bb dynamics
Explicitly modeling immune effector cell dynamics, while excluding immunodominance,
resulted in Bb population dynamics similar to observed experimentally (Figure 3-4A).
Antibody specificity estimated from the model was very high 𝑆𝑆(𝑖𝑖, 𝑗𝑗)7.5 . Similar to the

models including immunodominance, the relative abundance of Bb cells expressing the
parental VlsE decreased rapidly following the specific antibody response as was observed
in experimentally infected mice (Figure 3-4B). The simulation described temporal
fluctuations in abundances of both Bb populations and of immune effector cells (Figure
3-4C).
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Figure 3-4. Numerical simulations of Bb population dynamic models that include
immune effector dynamics can reproduce the data from experimental infections in mice.
(A) The Bb population dynamics predicted by the model that includes immune effector
cell dynamics replicates the data from experimental infections. Open circle, Bb levels
experimentally observed by Pahl et al. [60]. (B) The proportion of Bb cells retaining the
parental VlsE sequence predicted by the numerical simulation resembles the data
observed by Coutte et al. [20] in C3H mice. (C) The predicted dynamics of immune
effectors is out-of-phase with the Bb abundances, resembling classical predator-prey
dynamics.

3.3.5. VlsE diversity significantly influences Bb levels
Pairwise sequence similarities among VlsE variants (S(i,j)) generated from the natural vls
cassettes are significantly lower than those among VlsE variants generated by the
perturbed vls unexpressed cassettes (Figure 3-5). Pairwise sequence similarities among
variants generated by both the natural and the perturbed vls unexpressed cassettes are
negatively correlated with the number of recombination events that separate the variants
(Dr) (Figure 3-5). Because VlsE contains only a finite number of variable sites, the rate
of decrease in S(i,j) diminishes over time (Figure 3-5).
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Figure 3-5. Pairwise sequence similarity (S(i,j)) is greater among VlsE variants generated
by perturbed than natural vls unexpressed cassettes. Filled circle, VlsE variants generated
by the natural unexpressed cassettes; open circle, VlsE variants generated by the
perturbed unexpressed cassettes.

In both the antibody immunodominance and the immune effector dynamics models,
higher diversity among VlsE variants results in higher Bb density when immune
suppression impacts Bb population dynamics (Figure 3-6). When Bb population
abundances are strongly suppressed by antibodies, Bb with the natural cassettes were up
to 26% more abundant than Bb with the perturbed cassettes in the model that included
immune effector dynamics. In the model that included antibody immunodominance, Bb
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with the natural cassettes were up to 200% more abundant than Bb with the perturbed
cassettes.

Figure 3-6. Greater diversity among VlsE variants results in substantially higher densities
of Bb within hosts. The population dynamics of Bb with natural vls cassettes, and thus
greater within-host VlsE diversity, were substantially different that the dynamics of Bb
with perturbed cassettes in simulations that included immune effector dynamics (A) and
those that included antibody immunodominance (B). The left panels show the dynamics
of Bb populations with natural (solid lines) and perturbed (dotted line) vls cassettes

52

during the initial stages of infection. The right panels show the relative difference in
abundance of Bb populations with natural and perturbed vls unexpressed cassettes.

3.4 Discussion
A simple model of the Bb population dynamics in the face of antibody pressure cannot
account for Bb persistence within hosts following the rapid, antibody-mediated decline in
population sizes observed in experimental infections, regardless of the parameters used in
the model. These results suggest that mechanisms in addition to VlsE antigenic variation
may be necessary to explain the persistent within-host survival of Bb or that the efficacy
of the adaptive immune response wanes quickly in the early stages of infection.
Alternatively, two well-characterized mechanisms - antibody immunodominance or
immune effector cell dynamics - can account for the Bb population dynamics observed in
experimental infections [25, 62].
Including either immunodominance or fluctuation in immune effector cell abundances
into the Bb population dynamic model can replicate the Bb population dynamics
observed in experimental infections. However, the antibody specificity values (x)
necessary to recreate the observed dynamics vary between the models. Antibody
specificity can be relatively mild in the model including immunodominance while the
model with immune effector cell dynamics required little cross-reactivity to recreate the
Bb dynamics. Further, the models result in considerably different predictions of
population dynamics in Bb as well as differences in the effect of VlsE variability on
within-host Bb abundance. That is, models with antibody immunodominance predicts Bb
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abundance stabilizes after the early stages of infection, the level of which is largely
affected by the diversity at VlsE (Figure 3-6), while models including immune effector
cell dynamics predict continuous fluctuations in Bb abundance with only small effects of
VlsE diversity occurring only when population sizes are small (Figure 3-6). The
differences in the predictions of the models can be tested with experimental data to
estimate the likelihoods of processes occurring within hosts.
The effect of diversity among VlsE variants on the abundance of Bb within-hosts is most
apparent at low population densities. Low population density is a sign of strong immune
suppression, under which the ability to evade immune targeting is vital. Besides, at low
densities, VlsE sequences experience fewer recombination events per unit time, such that
high diversity- generating abilities of the unexpressed cassettes are vital for the
recombinants to be different enough from the parental VlsE to escape the immune
response. It is surprising, however, that small differences in sequence diversity have a
large effect on Bb dynamics. For instance, pairwise sequence difference among VlsE
variants produced by the two sets of unexpressed cassettes explored here differ by less
than 1% per recombination event, but the resulting difference in Bb abundance differed
by more than 200% for models that included immunodominance and as much as 26% for
models that included immune effector dynamics. The differences in Bb abundance likely
have effects on key evolutionary and pathological traits of Bb such as the probability of
dissemination to internal organs and the probability of transmission to feeding ticks.
The mechanisms resulting in the rapid decrease in Bb abundance followed by within-host
persistence also differ among the models. In the models that include immunodominance,
a single antibody type can rapidly eliminate the parental VlsE after the specific antibody
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response is initiated. This causes a rapid decrease in the Bb population that is composed
primarily of the parental VlsE. However, the lag time needed to initiate the immune
response allows a sufficient amount of recombination to occur in a fraction of the
population that is able to evade the antibody targeting the parental VlsE variant.
Subsequent antibody responses, coupled with the limit amount of recombination
occurring in the small Bb population, can control the Bb abundances within the host.
The models that include immune effector dynamics permit persistence due to predatorprey like dynamics. The recruitment rate of immune effector cells is a function of the
abundance of Bb leading to elevated killing when Bb level is high and reduced killing
when Bb is rare [68]. The immune effector dynamics deviate from the pure Lotka-Voltera
model in that there is an intrinsic rate of recruitment of the immune effector cells, which
can eliminate Bb at large values.
The models described in this chapter suggest testable hypotheses that may account for the
population dynamics of Bb within hosts. However, the quantitative predictions are likely
affected by several models assumptions. For example, the models were parameterized to
fit a sparse time series and thus likely suffer from over-fitting. Further, it is likely that
other unexplored mechanisms could also replicate the observed data assuming reasonable
parameters. Nevertheless, experimental data can differentiate the likelihoods of the
mechanisms proposed in each of the explored models given their divergences in
parameter values as well as the predictions of the relative effect of VlsE diversity on Bb
abundance.
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Chapter 4. Correlation between antigenicity and variability
of amino acid residues in VlsE
4.1. Introduction
The continual arms race between host immune responses and antigenic variation of
microbial parasites results in strong natural selection shaping the molecular interactions
at the antigen-antibody interface. For example, in the Lyme bacteria Borrelia burgdorferi
(Bb), continuous alteration of the surface antigen, VlsE, is required for the spirochete to
escape antibody recognition and establish long-term infections in vertebrate hosts [18,
21-24, 38]. Novel variants of VlsE are generated throughout vertebrate infections by
unidirectional recombination of a random segment from one of several unexpressed,
paralogous vls cassettes into the vlsE expression site [18, 19]. Variations among the
unexpressed vls cassettes are concentrated in six regions that correspond to the six
antibody-accessible, surface-loop structures of the VlsE protein [18, 69]. The probability
of evading detection by antibodies targeting previously expressed VlsE is expected to
correlate with the sequence variability of VlsE. As the sequence variability of VlsE is
correlated with the variability among the unexpressed vls cassettes, natural selection
should favor maximal among-cassette diversity in order to maximize alterations in the
VlsE sequence [27]. However, only a subset of the sites within the loop structures are
variable [18, 61]. The absence of variability at the remaining sites in the antigenicallyimportant loop structures suggests that these sites are either rarely targeted by antibodies
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or are constrained to be invariant by other selective forces such as maintenance of protein
structure or function.
The degree to which an antigen must change to escape binding by an antibody depends
largely on the physicochemical properties of the amino acids that are recognized by the
antibody. Antigen-antibody contact regions consist of an average of 18 amino acids in the
antigen [70], each of which has a quantitatively different effect on antibody-antigen
reactivity. Variation among amino acids in their effect on binding affinity has been most
strongly correlated with the solvent accessible surface areas of amino acid residues [71,
72]. Other physicochemical or statistical properties of amino acid residues including
hydrophilicity [73, 74] and statistical epitope propensity [75] are also correlated with
reactivity between residues and antibodies. Thus, the amino acid sites in VlsE that have
large solvent accessible surface areas, are hydrophilic, and have high epitope propensity
scores are likely to have the largest effect on immune evasion when mutated, and are thus
the sites that are expected to be variable among vls cassettes.
In this study, we investigated the structural and physicochemical properties of amino
acids in the antigenically-important surface loops of VlsE to assess if variable amino acid
sites have a larger effect on antibody reactivity. We addressed this hypothesis through
computational structural analyses of the VlsE antigen and by experimentally testing the
effect of altering variable or invariant sites on antibody reactivity.

4.2. Materials and Methods
4.2.1. Correlations between amino acid variability and metrics of antibody reactivity
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The published VlsE crystal structure from Bb clone 5A3 ([PDB:1L8W], chain B) [69]
was used to computationally investigate the hypothesis that amino acid residues that are
more reactive to antibodies are more likely to be altered during antigenic variation.
Variable and invariant amino acid sites in the surface exposed loops of VlsE were
identified as previously described [18, 61]. We used three metrics to assess reactivity to
antibodies; 1. solvent accessible surface area, 2. hydrophilicity, and 3. statistical epitope
propensity. Solvent accessible surface areas of each amino acid residue in the six surface
loops in VlsE were calculated based on the published VlsE crystal structure using the
POPS algorithms [76]. The hydrophilicity of each amino acid was estimated using the
Parker hydrophilicity scale [73]. Statistical epitope propensities (the log-odds ratio of the
frequencies of a type of amino acid appearing in known epitopes) were estimated as
previously described [75]. The solvent accessibility, hydrophilicity, and epitope
propensities of invariant VlsE amino acids – those that are never altered by
recombination with any vls cassette – were compared to the solvent accessibility,
hydrophilicity, and epitope propensities of variable amino acids.
4.2.2. Antibody binding sites predicted by computational docking analysis
Antibody reactivity of amino acid residues in VlsE was also computationally predicted by
conducting protein-protein docking analyses. 394 antibody light or heavy chains whose
structures have been solved were extracted from the Protein DataBase as described by
Kunik et al (structural consensus among antibodies). Automated protein docking was
performed between VlsE and each of the 394 antibodies light or heavy chains using the
ClusPro server under Antibody Mode. For each VlsE-antibody pair, the docking model
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with the highest score was used to identify the antibody-reactive amino acid residues in
VlsE. In each model, residues in VlsE that have any atoms that are less than 4A away
from any atoms in the antibody were identified as antibody-reactive. The number of times
a VlsE residue is identified as antibody-reactive in the 394 VlsE-antibody docking
models was used to infer the antibody reactivity of the residue.
4.2.3. Experimental effect of altering amino acid residues on antibody reactivity
The effect of changing either naturally variable or invariant amino acid sites in the
surface exposed loops of VlsE on antibody reactivity was investigated using recombinant
wild-type and mutant VlsE proteins. The DNA sequence of the wild-type vlsE was
amplified from Bb (clone 5A3) using primers 5A3F
(CGGGGATCCCAGCCAAGTTGCTGATAAGGACGACCC) and 5A3R
(CGGAAGCTTCAATCATGAGGGCATAGTCGTGTCCATACA). The ends of the
amplicon were digested with BamHI and HindIII prior to ligation into expression vector
pET45(b) (Novagen). The wild-type VlsE protein was expressed in E. coli BL21 (DE3),
purified using Ni-NTA Superflow Resin (Qiagen), and dialyzed overnight in 100mM
NaCl, 50mM Tris-8 and 0.1% Tween-20. Polyclonal antibodies against the wild-type
VlsE protein were generated in two rabbits at Anaspec, Inc. (Fremont, CA).
VlsE mutant proteins were generated by alanine scanning mutagenesis [77]. A single
amino acid was changed to an alanine using the Quikchange mutagenesis kit (Agilent
Technologies) in each of 28 VlsE mutant proteins, 18 of which are found in loop 1 and 10
in loop 4 (Figure 4-1). Loop 1 and Loop 4 were chosen because approximately half of the
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amino acid sites are variable in each of the two loops. VlsE mutant proteins were
expressed and purified as described for the wild-type VlsE protein.

Figure 4-1. The 28 VlsE mutant proteins used in this study. The amino acids replaced by
alanine in each of the mutant VlsE are shown in red. Sites coding for alanine in the wildtype protein were not altered. The amino acids that are naturally variable in surface
exposed Loops 1 and 4 are shaded in the wild-type (WT) amino acid sequences. Mutant
VlsE proteins are named after the location of the mutation in the wild-type protein. For
example, the mutation in mutant protein L1M140 is at the 140th amino acid residue which
falls in loop 1.
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ELISA was used to assess the effect of each mutation on antibody reactivity. However,
background noise associated with cross-reactive antibodies that bind both the wild-type
and mutant antigens in areas unaffected by the single amino acid substitution hindered
measurements of the effect of the mutated residue. In this study, background reactivity
was reduced by negative purification of the antisera (Figure 4-2). Negative purification
was performed by coating wells of standard ELISA plates with the focal VlsE mutant
(50μg/mL) diluted in PBS (4°C overnight), blocking with BSA diluent/blocking solution
(KPL; 4°C overnight), and then incubating rabbit antisera in wells for 90 minutes at room
temperature. The antibodies generated against the wild-type VlsE that bind to the focal
mutant, and are thus cross-reactive, were removed by repeating this process six times,
each time transferring the antisera into a new well coated with the same focal VlsE
mutant and incubating for 90 minutes (Figure 4-2A). After six rounds of negative
purification, only antibodies that bind to the wild-type but not to the mutant VlsE are
expected to remain in the antisera (Figure 4-2B).
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Figure 4-2. Negative purification of antisera for high-sensitivity ELISA by adsorption
with a focal VlsE mutant. (A) Cross-reactive antibodies are removed by adsorption to the
focal mutant antigen. The quantities of remaining antibodies, which are not cross-reactive,
are measure by ELISA using the wild-type antigen. (B) Negative purification of antisera
increases sensitivity in immuno-assays. Negative purification consistently reduced the
background noise in immuno-assays resulting in high precision data. In the figure,
antisera generated by rabbit II were progressively adsorbed with the wild-type or one of
two VlsE mutants. “0 Rounds” shows the reactivity of the antisera to the wild-type VlsE
without prior negative purification.

Post negative-purification antisera were used in a standard indirect ELISA using wildtype VlsE as the target antigen under standard procedures recommended by abcam, with
a final wild-type VlsE concentration of 7.5μg/mL used to coat ELISA wells. Goat-antirabbit HRP was used as the secondary antibody and Turbo TMB was used as the
chromogen. ELISA signals were measured by reading absorbance at 450nm (A450). The
ELISA signals reflect the amount of antisera that did not bind to the focal VlsE mutant
used for negative-purification, which correspond to the proportion of antibodies that do
not bind to the mutant VlsE due to the mutation (Figure 4-2A). That is, the quantity of the
antibodies remaining after negative-purification shows the effect of the amino acid
substitution on antibody reactivity (Figure 4-2B). All absorbance readings were
normalized by the absorbance reading from a control well on each ELISA plate to
account for among-plate variation. The control well used antisera adsorbed with the wild63

type VlsE. Thus, mutations that do not affect antibody reactivity result in a normalized
score (A450(mutant) / A450(wt)) equal to 1.

4.3. Results
4.3.1. Computationally-determined correlation between antibody reactivity and
variability of amino acid residues in VlsE
Amino acid sites that are variable during antigenic variation in all surface loops have
significantly larger solvent accessible surface areas, which is strongly associated with
antibody reactivity, than the invariant amino acid sites (Figure 4-3A). Further, surface
accessibility is greater at variable amino acid sites than at invariant sites that use the same
amino acid residue (Figure 4-3B). Amino acid sites that are variable during antigenic
variation also have significantly larger hydrophilicity and epitope propensity scores
(Figure 4-3C,D), both of which are associated with greater targeting by antibodies.
Unlike solvent accessible surface area, the hydrophilicity index and epitope propensity
score are not conditional on the three-dimensional structure of the protein. Consistently,
antibodies bind to variable amino acid sites significantly more often than the invariant
amino acid sites, as is demonstrated by the antibody-antigen docking analyses (Figure 43E).
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Figure 4-3. Metrics of antigenicity are significantly greater at variable amino acid sites
than at invariant sites. (A) Solvent accessible surface areas of the variable amino acid
sites are significantly greater than at the invariant sites in all surface loops. (B) Even
among sites that use the same amino acid, the solvent accessible surface area is greater at
variable sites than invariant sites. Only the seven types of amino acids that are found in
both the variable and invariant sites are shown. Hydrophilicity (C) and statistical epitope
propensity (D) are also significantly greater at variable sites than at the invariant sites in
all surface loops. (E) Antibody docking analysis also suggests that variable amino acid
residues have higher reactivity to antibodies.
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4.3.2. Inconsistent experimental correlation between antibody reactivity and variability
at amino acid sites in VlsE
Changes in antibody reactivity caused by experimentally altering variable or invariant
amino acid residues in two surface exposed loop regions are summarized in Table 4-1.
Although the amino acids that are altered during antigenic variation have greater solvent
accessibilities, are more hydrophilic, and have greater epitope propensities than invariant
sites, experimentally changing amino acids at variable sites to alanine does not result in a
greater reduction in antibody reactivity than experimentally changing invariant sites
(Figure 4-4). In fact, several invariant amino acids have large impacts on antibody
reactivity when mutated (Table 4-1). Among variable sites, there is a statistically
insignificant positive correlation between the changes in antibody reactivity due to a
mutation and accessible surface area (Figure 4-5). Changes in antibody reactivity caused
by each experimentally-introduced mutation were varied considerably among the antisera
from different rabbits, thus resulting in inconsistent correlations between antibody
reactivity and solvent accessibility (Figure 4-6).
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Mutant

Solvent accessible surface
area of the mutated residue
(A2)

A450(mutant) /
A450(wt)

A450(mutant) /
A450(wt)

Rabbit I

Rabbit II

L1M140

21.58

1.116±0.066

1.202±0.097

L1M141

55.93

1.200±0.096

1.222±0.087

L1M142

19.53

1.390±0.097

1.490±0.059

L1M143

114.28

1.818±0.094

1.967±0.055

L1M146

17.91

3.086±0.148

1.380±0.037

L1M147

22.84

1.929±0.093

2.055±0.046

L1M148

43.95

1.683±0.205

1.982±0.128

L1M149

24.52

1.342±0.026

1.513±0.121

L1M150

24.17

1.800±0.229

1.436±0.086

L1M152

97.37

1.822±0.128

1.362±0.077

L1M154

147.16

1.815±0.034

1.427±0.079

L1M157

105.54

1.066±0.029

1.240±0.073

L1M158

56.74

1.590±0.064

1.382±0.033

L1M160

35.15

3.208±0.155

1.502±0.047

L1M161

125.25

2.801±0.120

1.670±0.094

L1M163

11.86

1.204±0.025

1.362±0.062

L1M164

13.54

2.760±0.142

1.340±0.096

L1M165

62.07

1.476±0.126

1.806±0.180

L4M243

151.12

1.101±0.116

1.667±0.254

L4M244

42.81

1.034±0.128

1.559±0.216

L4M245

77.87

1.104±0.063

1.494±0.185

L4M246

21.14

1.208±0.042

1.570±0.097

L4M247

68.7

1.769±0.088

1.344±0.022

L4M248

43.6

1.315±0.048

1.657±0.153
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L4M249

13.01

1.692±0.069

1.842±0.161

L4M250

36.63

1.268±0.052

1.396±0.071

L4M251

83.14

2.863±0.269

1.502±0.085

L4M253

76.93

1.373±0.147

1.415±0.079

Table 4-1. Antibody reactivity of mutated amino acid residues in 28 VlsE mutants.
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Figure 4-4. Changes in antibody reactivity caused by mutating variable or invariant
amino acid residues. Mutations at variable amino acid sites do not provide a greater
reduction in antibody reactivity than mutations at invariant sites. The expected decrease
in antibody binding caused by mutations in variable sites was detectable only in the
antibodies targeting loop 4 from rabbit I but not antibodies from rabbit II. Mutations in
the invariant sites of loop 1 had a greater effect on antibody reactivity than mutations to
variable sites in antibodies from rabbit I but not rabbit II.
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Figure 4-5. Correlation between antibody reactivity and the solvent accessible surface
area of variable amino acid residues. Change in antibody reactivity caused by changing a
single residue at a variable site is weakly and insignificantly correlated with the solvent
accessible surface area of the amino acid residue.
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Figure 4-6. Immune reactivity to the same VlsE mutants was inconsistent among antisera
raised in different rabbits. ELISA results were shown for each VlsE mutant reacting with
negatively purified antisera generated from rabbit I and rabbit II.

4.3.3. Data reliability after negative purification
Negative purification successfully reduced background variation in ELISA and the results
were repeatable. For example, antisera (from rabbit II) adsorbed using the wild-type VlsE
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or two mutant VlsE variants (L1M160 or L4M253) exhibited decreasing variance in
ELISA readings with increasing rounds of negative purification (Figure 4-2B).
Adsorption with wild-type VlsE followed by ELISA using wild-type VlsE as the target
antigen consistently resulted in the weakest signal, as expected. Adsorption with mutant
L1M160 followed by ELISA using wild-type VlsE as the target antigen consistently
resulted in a greater ELISA signal than adsorption with mutant L4M253, regardless of the
number of rounds of negative purification. Interestingly, antibody reactivity to each VlsE
mutant differed qualitatively among antisera from different rabbits (Figure 4-6). That is, a
VlsE mutant that resulted in a large reduction in antibody reactivity in one rabbit may
have had only a moderate impact on antibody reactivity using the antisera from a
different rabbit.

4.4. Discussion
Antigenic variation systems in pathogens generate divergent antigens in order to evade
recognition by host antibodies. Natural selection is expected to favor alterations at amino
acid positions that effectively reduce antibody reactivity [27, 61]. Thus, naturally
occurring changes in antigens are expected to occur at amino acid positions that are
commonly and effectively targeted by antibodies [78, 79]. By computationally analyzing
the structural features of VlsE, we found that amino acid positions that are most likely to
be variable in a primary surface antigen of Bb, VlsE, are those with properties associated
with high antibody reactivity including larger accessible surface areas, higher
hydrophilicity, and higher epitope propensity scores (Figure 4-3). The correlation
between accessible surface area and the antigenic importance of amino acids is well72

established and is one of the most important variables used in epitope prediction [71, 72].
Indeed, the correlation between variability and antigenicity is further supported by the
results from antibody docking analysis. However, prediction from accessible surface area
and antibody docking relies on the accuracy of the crystal structures and is thus subject to
crystallization artifacts. Hydrophilicity and statistical epitope propensity scores, on the
other hand, are crystal structures-independent and were also greater at variable sites than
invariant sites. The agreement among the crystal structure-dependent and independent
results is consistent with the hypothesis that variable amino acids are more likely to be
targeted by antibodies than invariant amino acids.
Nonetheless, the support for the hypothesis that variable amino acids in VlsE have a
greater effect on antibody reactivity is weak and inconsistent in the experimental data
(Figure 4-4, 4-5). Despite limited surface exposure and no potential to vary in the face of
antibody pressure, many invariant amino acids had as great an effect on antibody
reactivity as did variable sites (Figure 4-4). For example, mutations at two invariable sites
(L1M146 and L1M160) cause the largest reductions in antibody reactivity in rabbit I
antisera among all mutants (Table 4-1). One explanation for the discrepancy in the
computational and experimental results is that the computational results are artifacts.
However, this explanation is not likely given the consistency among the results from four
computational matrices. Another possible explanation is that altering naturally invariant
amino acids, which have less surface exposure and are more hydrophobic, destabilizes
protein structure [80] resulting in conformational changes that strongly affect antibody
binding [81]. The effect of altering invariant amino acids on the conformational stability
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and function of VlsE is likely to be highly detrimental and thus selected against [31],
despite the potential advantages for antigenic escape. Future investigations into the
structural and molecular changes caused by mutating variable and invariant sites may
identify targets of natural selection that have organized the locations and composition of
residues at sites that are variable among the vls cassettes.
The weak and inconsistent experimental patterns in antibody reactivity reductions may
also be caused by the stochasticity in immune development among animals, the limited
effects of alanine on antibody reactivity, or the limited effect of changing only one amino
acid on antibody reactivity. Antisera from the different rabbits often had different
reactivity to the same VlsE mutant (Figure 4-6). For example, one mutation in loop 1
(L1M160) resulted in the most dramatic decline in antibody reactivity among all
mutations from rabbit I antisera but only moderate declines in reactivity from rabbit II
antisera. Variation among individuals in epitope targeting is common (for example see
[82]), suggesting that antisera from a large number of experimental animals may be
necessary to deduce general trends.
The inconsistent empirical patterns may also be attributed to the use of alanine scanning
mutagenesis. Alanine scanning is a conservative technique used to understand the
functional effects of individual sites in a protein because alanine is likely to have the least
effect on protein structure due to limited steric and charge effects [83]. Although
conservative, alanine scanning mutagenesis did reveal an empirical relationship between
antibody reactivity and accessible surface area among the variable amino acid sites. This
pattern was, however, much less clear than the correlation between accessible surface
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areas and variability demonstrated computationally. Experimentally replacing the focal
amino acids with residues that are found in naturally occurring VlsE variants may reveal
a clearer pattern consistent with the hypothesis that natural selection influences both the
sites that are variable and the types of residues used at those sites [61]. However,
invariant sites do not have alternative residues in naturally occurring VlsE variants. Thus,
only conservative techniques such as alanine scanning allow for comparisons of the
effects of altering variable and invariant sites.
Investigating changes in antibody reactivity by altering amino acids individually may
have resulted in empirical patterns that were less consistent than computational
predictions due to the limited impact of individual amino acids. In natural Bb infections,
an average of 5 to 89 nucleotides are altered during each recombination event [20],
suggesting that changing more than one amino acid may be needed to detect
consequential reductions in antibody reactivity. Further, the combination of altered amino
acids may have an epistatic effect on antibody reactivity that would not be detected with
the alanine scanning approach. Although changes in antibody reactivity caused by one
amino acid substitution may be difficult to detect empirically, removal of the background
noise by negative purification of antisera enabled precise estimates of changes in
antibody reactivity. Negative purification is a useful tool to increase sensitivity of ELISA
and other antibody-based immunoassays that can be coupled with semi-rational
mutagenesis methods for high-throughput mapping of polyclonal epitopes.
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Chapter 5. Discussion
The ability of microbes to maintain high diversity is important for survival within adverse
and rapidly changing environments [84, 85]. As an example, the vls antigenic variation
system in the Lyme disease bacteria Borrelia burgdorferi (Bb) continuously generates
diversity at a site coding for an immunodominant surface antigen, VlsE, facilitating
evasion from host antibody recognition and is required for establishing long term
infection [18, 22-24, 38, 39]. The vls antigenic variation system is not only an essential
component in the pathogenesis of Bb but also a typical molecular mechanism bacteria use
to cope with rapidly changing environments. Recognizing the clinical and evolutionary
importance of the system, we studied the forces of natural selection that drive the
evolution of the vls antigenic variation system in the work presented in Chapter 2,
Chapter 3 and Chapter 4 of this thesis. Below we discuss the major findings, broad
significance, applications and limitations of the studies presented in each chapter.
In Chapter 2 we studied selection for sequence-level diversity among VlsE variants and
translational optimality of VlsE variants. The recombination events between vlsE and the
vls unexpressed cassettes were modeled according to experimentally derived data. By
modeling and simulating antigenic variation, we described the array of VlsE variants that
can be generated by the natural vls antigenic variation system and compared those to the
VlsE variants generated from cassettes that were computationally perturbed. This
computational method can be applied to identify evidence of natural selection in similar
systems that alter antigenic sequences using recombination-based mechanisms, such as
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Plasmodium falciparum [86] and Neisseria meningitides [87]. The predictions made by
the computational method can be empirically tested by competitive, mixed infection of
vertebrate hosts using the natural strain of Bb and genetically modified Bb strains that
carry perturbed unexpressed cassettes.
In this Chapter, we showed that the nucleotide identities at and positions of the variable
sites within the variable regions of the vls antigenic variation system are organized to
promote diversity among VlsE variants, consistent with the hypothesis that higher
diversity should be favorable within an adversely changing environment. In addition, we
found that translational ability and efficiency of the VlsE variants may constrain the
selection for higher sequence diversity. Although these findings are statistically
significant, in terms of effect size, the difference in VlsE sequence diversity and codon
optimality between natural and perturbed antigenic variation systems is small. Therefore,
Chapter 2 provides statistical evidence that both diversifying and stabilizing selection has
acted on the vls antigenic variation system, but the fitness impact of such selections is
unclear. It is also unclear how selection affects biological traits of Bb, such as the
dynamics of Bb within vertebrate hosts.
In Chapter 3, we investigated the biological significance of the diversity among VlsE
variants. Specifically, we studied how strongly the sequence diversity among VlsE
variants can affect Bb dynamics within vertebrate hosts. First, we mathematically
modeled Bb dynamics within vertebrate hosts and then asked if the dynamic models,
accounting for different microbiological and immunological mechanisms, can replicate
experimental data. We showed that to reproduce the experimental time series of Bb
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abundance observed in laboratory mice, the dynamic models need to include mechanisms
supporting immune evasion or fluctuating immune pressure, in addition to antigenic
variation in VlsE. We reproduced the experimental data by including two mechanisms –
antibody immunodominance and fluctuation of immune effector cells – independently
into the dynamic model. The two mechanisms are well-characterized and commonly
happen during early stages of bacterial infections [25, 68]. It is important to note that the
dynamic models are not suitable for making quantitative predictions because, first, the
two mechanisms are not mutually exclusive; second, the experimental time series may
also be reproduced under other mechanisms such as dissemination of the bacteria to
different infection sites. However, the two dynamics models make qualitatively different
predictions of the Bb dynamics when accounting for the two mechanisms: The model that
includes antibody immunodominance predicts that the Bb abundance will decrease to a
stable level following the initial expansion of antibodies, while the model including
immune effector cells predicts that the Bb abundance will fluctuate continuously. Such
difference can be tested experimentally to compare the likelihood of the two mechanisms.
Finally, we used the dynamics model to explain the biological significance of the
diversifying selection among VlsE variants identified in Chapter 2. We demonstrated that
a small difference in VlsE diversity can translate into significantly different Bb level
when immune clearance is efficient, suggesting that a small difference in genetic
diversity could result in substantial variation in a relevant trait value.
In Chapter 4, we studied natural selection that acts on structure-level properties of VlsE.
Specifically, we tested the hypothesis that the variable amino acid residues in VlsE are
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more likely targeted by antibodies than the invariable residues. Variability of amino acid
residues in VlsE was positively correlated to four different matrices that predict antibody
reactivity of the residues, consistently supporting the hypothesis that variable amino acid
residues in VlsE are more likely targeted by antibodies than the invariable residues.
However, this hypothesis was not supported by experimental epitope mapping data:
Mutating a naturally variable residue did not always result in a greater reduction in
antibody reactivity than mutating a naturally invariable residue. There are several
mechanisms that could explain such discrepancies. First, the computationally determined
correlations between variability and antigenicity may be artifacts. Second, the biological
signal could be obscured by noise from alanine-scanning mutagenesis and diversity
between the immune systems of the rabbits used to raise the antibodies. Third, the
discrepancy could be due to purifying selection acting on the invariable residues to
prevent structural perturbation of the VlsE protein. In particular, the third potential
mechanism described a set of conflicting selective forces that promote antigenic diversity
while maintaining the structure of the protein. The hypothesis is biologically intriguing
and can be tested by analyzing the structural effect of mutating naturally variable or
invariable amino acid residues in VlsE.
Consistent with the expectations, our findings suggest that rapidly changing
environments select for higher diversity at the locus encoding for molecules at the
interface of the microbe and the environment, such as the variable protein antigen VlsE
[12, 84, 85]. Each variant of the molecule permits survival within only a subset of the
temporally variable environmental states. For example, each VlsE variant can evade
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certain types of antibodies but is effectively targeted by other antibodies. Therefore,
microbial populations can track and survive multiple environmental states by maintaining
high diversity at such loci [85, 88]. It is worth noting that diversity can be measured in
different traits: from genetic diversity (diversity on sequence level) to diversity at
different levels of organization such as protein structure, antibody reactivity and
microbial fitness. The thesis demonstrates that, although the traits at these levels of
organization are derived from the same genetic basis, their patterns of diversity may
differ. For instance, in Chapter 3 we showed that small sequence diversity among VlsE
variants can translate into substantially larger difference in Bb abundance; in Chapter 4
we showed that mutating a single amino acid residue at different positions in different
VlsE variants, resulting in the same degree of sequence difference between the mutants
and the wild-type VlsE, can lead to substantially different interactions with the same
polyclonal antibodies. The different patterns of diversity may result from the fact that
traits are connected nonlinearly by biological processes such as gene expression, protein
folding and localization, antibody-antigen interaction and immune selection. Moreover,
diversity in different traits is likely constrained by various types of stabilizing or
purifying selections. For instance, this thesis suggests that the diversity of VlsE variants
at the DNA-sequence level is likely constrained by translational efficiency of the VlsE
variants, and that diversity at protein structure level might be constrained by natural
selection for the structural stability of the protein.
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